|
⚲
|
| Keyboard |
| Heyman Tomas J
✚
|
|
|---|---|
| CIK # | 0001814673 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001814673] | |
| 4 | [0001814673] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Heyman Tomas J | |
| Exelixis Inc | |
| Legend Biotech Corp | |
| Akero Therapeutics Inc | |
| OptiNose Inc | |
| Xilio Therapeutics Inc | |
| Invivyd Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 13,000 | ||
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 15,000 | ||
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 15,000 | ||
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 26,000 | ||
|
Akero Therapeutics Inc AKRO
Common Stock
|
2025-12-09 | Disposed to issuer | 9,398 | ||
|
Akero Therapeutics Inc AKRO
Common Stock
|
2025-06-03 | Grant | 9,398 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2025-05-29 | Grant | 9,812 | $0.00 | |
|
OptiNose Inc OPTN
Stock Option (Right to Buy) · derivative
|
2025-05-21 | Disposed to issuer | 962 | ||
|
OptiNose Inc OPTN
Stock Option (Right to Buy) · derivative
|
2025-05-21 | Disposed to issuer | 2,133 | ||
|
OptiNose Inc OPTN
Stock Option (Right to Buy) · derivative
|
2025-05-21 | Disposed to issuer | 3,566 | ||
|
OptiNose Inc OPTN
Stock Option (Right to Buy) · derivative
|
2025-05-21 | Disposed to issuer | 5,000 | ||
|
OptiNose Inc OPTN
Stock Option (Right to Buy) · derivative
|
2025-05-21 | Disposed to issuer | 1,925 | ||
|
Exelixis Inc EXEL
Common Stock
|
2025-05-21 | Sell | 4,544 | $44.29 | 201,254 |
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2024-06-08 | Grant | 26,000 | $0.00 | |
|
OptiNose Inc OPTN
Stock Option (Right to Buy) · derivative
|
2024-06-06 | Grant | 75,000 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2024-05-31 | Grant | 18,838 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2023-06-23 | Grant | 15,000 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2023-06-16 | Sell | 26,000 | $54.67 | 1,421,420 |
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2023-06-16 | Option exercise | 26,000 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2023-06-16 | Option exercise | 26,000 | $25.04 | 651,040 |
| showing 20 of 33 most recent transactions | |||||